Bioseeker, Feb 2011
and the accumulated number of ceased drugs over the last years amount to another 146 (132) drugs. Apoptosis In OncologyDrugPipelineUpdate lists all drugs and gives you a progress analysis on each one of them
Bioseeker, Dec 2011
and Position of Others
Apoptosis in Oncology: PipelineUpdate 2011-.
The Package Includes
- A progress analysis on current and emerging drugs
- Information on most companies active in apoptotic drug R
Datamonitor, April 2010, Pages: 243
with greater efficacy
Small molecules
Small molecules targeting tyrosine kinases have been a significant development in oncologydrug discovery
Classification of pipeline products
Angiogenesis inhibitor
Bioseeker, Sep 2007, Pages: 500
by Cancer Indications
7.3 Deployment of Natural Product Compounds by Cancer Indications
8 Drug Development in Oncology by Major Targeted Therapy Areas
8.1 Angiogenesis
8.2 Antibodies
8.3 Apoptosis
8
Bioseeker, Dec 2007, Pages: 430
& Immunostimulation
22.2 Small molecules: Apoptosis inducers & Kinase inhibitors
23 Competitive Landscape in Lymphoma Drug Development: The Late Stage Pipeline
24 Current Lymphoma Drug Development: The Early Stage
Bioseeker, Jan 2007, Pages: 750
this analysis to drive strategic planning decisions in oncologydrug development TOP 7 CANCER INDICATIONS
THERAPEUTIC & COMPETITIVE INSIGHTS
1 EXECUTIVE SUMMARY
2 TABLE OF CONTENTS
21 LIST BOXES
22 LIST
Bioseeker, May 2006, Pages: 110
.1 Antibodies & Immunostimulation
8.2 Small molecules: Apoptosis inducers & Kinase inhibitors
9 Competitive Landscape in Drug Development: The Late Stage Pipeline
10 Current Drug Development: The Early Stage
Espicom Business Intelligence Ltd, Dec 2005, Pages: 480
(numbers and rates per 100,000 population);
- Drugs on the Market- Branded and generic products with monographs and sales figures, where available;
- Ongoing R&D - Drugs in the pipeline;
- Who's Working
